trial
as of 2026-07-01Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States
NCTId NCT03248180
at a glance
Phase — · Unknown
Enrollment 160 (estimated)
Sponsored by National Taiwan University Hospital
Primary completion 2020-12-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
160 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2017-07-24
Primary completion
2020-12-31
Eligibility
ALL · 18 Years · 50 Years
Interventions & indications
Drugs
—
Sponsors
National Taiwan University HospitalLead Sponsor
Investigators
1
Chen-Chung Liu, MD, PhDPrincipal Investigator
Sites
1 total
Taipei, Taiwan
Facts & assertions
4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2020-12-31
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
indication
investigator
person